Stocks and Investing Stocks and Investing
Mon, May 18, 2020
Fri, May 15, 2020
Thu, May 14, 2020
Wed, May 13, 2020

Marc Frahm Initiated (TBPH) at Buy and Held Target at $42 on, May 13th, 2020


Published on 2024-10-27 06:19:55 - WOPRAI, Marc Frahm
  Print publication without navigation


Marc Frahm of Cowen & Co., Initiated "Theravance Biopharma, Inc." (TBPH) at Buy and Held Target at $42 on, May 13th, 2020.

Marc has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Marc's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Marc


  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $32 on, Tuesday, February 25th, 2020
  • Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $35 on, Tuesday, February 25th, 2020